Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Investing

Pfizer : PFE

All Pfizer Articles

1508 Articles

Joel South | Apr 23, 2026 at 10:07 AM EDT

Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks

Market volatility has rattled portfolios in 2026, with broad equity indexes absorbing sharp swings tied to tariff uncertainty and shifting…

Drew Wood | Apr 21, 2026 at 1:17 PM EDT

Just Five Dividend Stocks Transform $500,000 Into $3,100 a Month in Retirement Income

A $500,000 retirement portfolio spread across five income-focused stocks can generate a blended yield of roughly 7.4%, translating to about…

Vandita Jadeja | Apr 17, 2026 at 10:22 AM EDT

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record…

Lee Jackson | Apr 16, 2026 at 7:57 AM EDT

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Pre-Market Stock Futures: The futures are trading modestly higher after a wild Wednesday that saw the Nasdaq explode higher to…

Drew Wood | Apr 14, 2026 at 9:00 AM EDT

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Two million dollars in four household-name dividend payers can generate between $132,000 and $146,000 in annual income. That is the…

Drew Wood | Apr 14, 2026 at 8:00 AM EDT

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it…

Vandita Jadeja | Apr 6, 2026 at 12:15 PM EDT

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two…

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

Trey Thoelcke | Mar 26, 2026 at 7:55 AM EDT

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

Pfizer (NYSE: PFE | PFE Price Prediction) is one of the most widely held dividend stocks among retirement investors. The…

Joey Frenette | Mar 25, 2026 at 12:23 PM EDT

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer…

Joel South | Mar 24, 2026 at 10:52 AM EDT

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Pfizer (NYSE:PFE | PFE Price Prediction) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over…

Lee Jackson | Mar 18, 2026 at 7:19 AM EDT

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on…

Lee Jackson | Feb 12, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open…

Vandita Jadeja | Feb 11, 2026 at 10:00 AM EST

Ultra-High Yield Dividend Stocks Yielding More Than 5%

Choosing the right investment vehicles can ensure steady income and wealth generation. Growth stocks are often considered to be an…

David Moadel | Feb 6, 2026 at 3:37 PM EST

3 High-Yield Dividend Stocks Perfect For Retirees

What does a successful retirement look like? If it means financial security through steady income sources, then you can get…

1 2 3 4 5 6 … 101

Pfizer : PFE

All Pfizer Articles

Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks

Just Five Dividend Stocks Transform $500,000 Into $3,100 a Month in Retirement Income

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Ultra-High Yield Dividend Stocks Yielding More Than 5%

3 High-Yield Dividend Stocks Perfect For Retirees

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

CIBR vs. HACK: Which Cybersecurity ETF Is the Smarter Way to Play Digital Defense?

Bezos Is Raising $10 Billion for His Rocket Company, After SpaceX Made Musk A Trillionaire

5 High-Yield Dividend Stocks Yielding 5% or More to Buy in July

How the Average Retiree's $330,186 Quietly Pushes Their Social Security Into Taxable Territory

The Retirement Income Strategy That Helps Investors Avoid Selling During 20% Market Drops

Prediction: Tesla Stock Will Surprise Investors Over the Next 5 Years

INDA vs. EPI: Which India ETF Best Captures the World’s Fastest-Growing Big Economy?

Pfizer : PFE

All Pfizer Articles

Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks

Just Five Dividend Stocks Transform $500,000 Into $3,100 a Month in Retirement Income

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Ultra-High Yield Dividend Stocks Yielding More Than 5%

3 High-Yield Dividend Stocks Perfect For Retirees

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

CIBR vs. HACK: Which Cybersecurity ETF Is the Smarter Way to Play Digital Defense?

Bezos Is Raising $10 Billion for His Rocket Company, After SpaceX Made Musk A Trillionaire

5 High-Yield Dividend Stocks Yielding 5% or More to Buy in July

Featured Reads

How the Average Retiree's $330,186 Quietly Pushes Their Social Security Into Taxable Territory

The Retirement Income Strategy That Helps Investors Avoid Selling During 20% Market Drops